Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02162836
What this trial is testing

A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Pharmaceutical K.K. 6
Testing effectiveness (Phase 2)Ended earlyNCT00293371
What this trial is testing

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 6
Large-scale testing (Phase 3)Study completedNCT02288247
What this trial is testing

Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Europe Ltd. 688
Testing effectiveness (Phase 2)Study completedNCT02278055
What this trial is testing

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerPain
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00706498
What this trial is testing

Phase II Study of BI 2536 in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)Ended earlyNCT01845792
What this trial is testing

Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Colorado, Denver 7
Early research (Phase 1)Study completedNCT01187485
What this trial is testing

Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 15
Large-scale testing (Phase 3)Study completedNCT00046943
What this trial is testing

Atrasentan in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Abbott
Testing effectiveness (Phase 2)UnknownNCT04926155
What this trial is testing

The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 234
Not applicableStudy completedNCT04281147
What this trial is testing

Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

Who this might be right for
Prostate Cancer
Bayer 4,301
Large-scale testing (Phase 3)Study completedNCT00744497
What this trial is testing

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bristol-Myers Squibb 1,930
Early research (Phase 1)Ended earlyNCT05999968
What this trial is testing

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Who this might be right for
Prostatic Neoplasms
Eli Lilly and Company 10
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Large-scale testing (Phase 3)Study completedNCT01707966
What this trial is testing

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 47
Early research (Phase 1)Looking for participantsNCT07145177
What this trial is testing

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT00473746
What this trial is testing

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 66
Testing effectiveness (Phase 2)Looking for participantsNCT04038502
What this trial is testing

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate CancerBARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2RAD51B, RAD51C, RAD51D, or RAD54L Mutations
VA Office of Research and Development 100
Testing effectiveness (Phase 2)Study completedNCT03568656
What this trial is testing

Study to Evaluate CCS1477 in Advanced Tumours

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more
CellCentric Ltd. 219
Not applicableWithdrawnNCT04742972
What this trial is testing

Prostate PMSABR Study

Who this might be right for
Prostate Cancer
Darren Poon
Large-scale testing (Phase 3)Looking for participantsNCT06925737
What this trial is testing

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Who this might be right for
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC 1,440
Next Page